Stay updated on IMO-8400 Extension in Waldenström's Macroglobulinemia Clinical Trial
Sign up to get notified when there's something new on the IMO-8400 Extension in Waldenström's Macroglobulinemia Clinical Trial page.

Latest updates to the IMO-8400 Extension in Waldenström's Macroglobulinemia Clinical Trial page
- Check6 days agoChange DetectedThe page now displays the study record for the IMO-8400 extension trial in patients with Waldenström’s macroglobulinemia, including study design, eligibility criteria, treatment details, and safety outcome measures. It also shows the completed study status and registration and results dates.SummaryDifference33%

- Check13 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.2 to v3.8.0, while the study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check20 days agoChange DetectedA notice was added about NIH websites transitioning terminology from “Artificial Intelligence” to “Super Intelligence,” with a link to updates and FAQs.SummaryDifference1%

- Check27 days agoChange DetectedThe site footer revision label changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check34 days agoChange DetectedThe ClinicalTrials.gov 403 Forbidden page identifies the site revision as v3.7.1 instead of v3.7.0.SummaryDifference0.2%

- Check55 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the study content with an access-denied message. As a result, the study details are not visible while the error persists.SummaryDifference15%

Stay in the know with updates to IMO-8400 Extension in Waldenström's Macroglobulinemia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMO-8400 Extension in Waldenström's Macroglobulinemia Clinical Trial page.